People · Operator
Named in public records as an officer, director or promoter · active 2011–2023 · Software / Tech, Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| JenaValve Technology Inc | — | Software / Tech | Series D+ | $328.5M | $2.2B | 2018 |
| Accutar Biotechnology Inc. | — | Biotechnology | Series B | $76.5M | $940.7M | 2019 |
| OriGene Technologies, Inc. | — | Biotechnology | Series B | $38.6M | $676.8M | 2012 |
| Tiger Biotherapeutics Inc. | — | Other Technology | Series B | $20.0M | $234.1M | 2023 |
| Wupima Inc | — | Other Technology | Pre-Seed | $963K | $40.8M | 2011 |
Quan Zhou at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Quan Zhou on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jie FAN | 2 | 2 |
| Peter Barrett | 1 | 18 |
| BIHUA CHEN | 1 | 14 |
| Robert Mitchell | 1 | 9 |
| Andrew Hack | 1 | 5 |
| Wei-Wu He | 1 | 4 |
| Rudi Marien | 1 | 3 |
| Wei He | 1 | 3 |
| James Hu | 1 | 3 |
| Kenneth MacLeod | 1 | 3 |
| Jan Pensaert | 1 | 3 |
| Jose Calle Gordo | 1 | 2 |
| Peter Wulff | 1 | 2 |
| Daniel Dearen | 1 | 2 |
| John Kilcoyne | 1 | 2 |
| Olivier Litzka | 1 | 2 |
| Anil Gupta | 1 | 2 |
| Regina Hodits | 1 | 2 |
| Victoria Carr-Brendel | 1 | 2 |
| Ouyang Xiangyu | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.